Teva Pharmaceutical Industries (TEVA) News Today → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free TEVA Stock Alerts $17.12 -0.04 (-0.23%) (As of 06/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 14, 2024 | marketbeat.comBurford Brothers Inc. Takes $1.46 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Burford Brothers Inc. bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 139,699 shares of the companJune 13, 2024 | reuters.comTeva sues Corcept over mifepristone 'monopoly' for rare disorderJune 13, 2024 | marketbeat.comGlenview Capital Management LLC Invests $16.75 Million in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Glenview Capital Management LLC bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,604,633 shares of the company's stock, valued at appJune 13, 2024 | marketbeat.comWhat is a Bull Flag Pattern? Explanation and ExamplesLearn how to identify and trade the bull flag pattern, which is a key tool for spotting continuations in bullish trends.June 12, 2024 | marketbeat.comADAR1 Capital Management LLC Makes New $1.16 Million Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)ADAR1 Capital Management LLC acquired a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 111,326 shares of the compJune 11, 2024 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Reaches New 52-Week High at $17.54Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 1-Year High at $17.54June 11, 2024 | seekingalpha.comTeva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)June 10, 2024 | marketbeat.com235,700 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Acquired by CastleKnight Management LPCastleKnight Management LP bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 235,700 shares of the company's stock, valuedJune 9, 2024 | marketbeat.comRubric Capital Management LP Has $190.29 Million Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Rubric Capital Management LP lessened its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 4.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,226,601 shares of the company's stJune 7, 2024 | seekingalpha.comTeva Pharmaceutical: Buy This Bargain Before It's GoneJune 5, 2024 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Given New $21.00 Price Target at BarclaysBarclays upped their price objective on Teva Pharmaceutical Industries from $20.00 to $21.00 and gave the company an "overweight" rating in a research note on Wednesday.June 4, 2024 | marketbeat.comNorges Bank Purchases New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Norges Bank purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 1,377,000 shares of the company's stock, valued at approximatelyJune 3, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Stake Boosted by Lingotto Investment Management LLPLingotto Investment Management LLP grew its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 1.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,457,656 shares of theJune 3, 2024 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Reaches New 12-Month High at $17.37Teva Pharmaceutical Industries (NYSE:TEVA) Sets New 1-Year High at $17.37June 2, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Acquired by Hsbc Holdings PLCHsbc Holdings PLC increased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 242.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,597,178 shares of tJune 1, 2024 | businesswire.comNew Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate)June 1, 2024 | businesswire.comTeva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024June 1, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Allianz Asset Management GmbHAllianz Asset Management GmbH lessened its stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 27.4% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,102,814 shares of the company'sMay 31, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited Expected to Earn FY2025 Earnings of $2.51 Per Share (NYSE:TEVA)Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Equities researchers at Zacks Research upped their FY2025 EPS estimates for Teva Pharmaceutical Industries in a research note issued on Wednesday, May 29th. Zacks Research analyst R. Department now forecasts that the company willMay 31, 2024 | marketbeat.com2 Generic Drug Makers With Growing RunwaysBrand-name drug costs continue to climb, but patients and insurers find respite by migrating to generic or biosimilar versions as patents run out. Generics are loved by health insurers, Medicare, and patients as they contain the same compounds and active ingredients for a cheaper price.May 31, 2024 | marketbeat.com2 Generic Drug Makers With Growing RunwaysBrand name drug costs continue to climb but patients and insurers find respite by migrating to generic or biosimilar versions as patents run out.May 30, 2024 | marketbeat.comBank of America Boosts Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $21.00Bank of America raised their price objective on shares of Teva Pharmaceutical Industries from $18.00 to $21.00 and gave the stock a "buy" rating in a report on Thursday.May 30, 2024 | marketbeat.comZacks Research Equities Analysts Reduce Earnings Estimates for Teva Pharmaceutical Industries Limited (NYSE:TEVA)Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Equities research analysts at Zacks Research decreased their Q2 2024 EPS estimates for Teva Pharmaceutical Industries in a research note issued on Wednesday, May 29th. Zacks Research analyst R. Department now anticipates that theMay 25, 2024 | marketbeat.comAbrams Capital Management L.P. Sells 1,969,597 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Abrams Capital Management L.P. reduced its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 24.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,996,836 shares of the compaMay 21, 2024 | msn.comTeva, Alvotech launch biosimilar against AbbVie’s HumiraMay 21, 2024 | marketbeat.comStockNews.com Lowers Teva Pharmaceutical Industries (NYSE:TEVA) to BuyStockNews.com downgraded shares of Teva Pharmaceutical Industries from a "strong-buy" rating to a "buy" rating in a report on Monday.May 20, 2024 | markets.businessinsider.comTeva Says Simlandi Injection Now Available In U.S.May 20, 2024 | marketbeat.comTraders Buy Large Volume of Teva Pharmaceutical Industries Call Options (NYSE:TEVA)Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) was the recipient of some unusual options trading activity on Monday. Stock traders bought 42,625 call options on the stock. This is an increase of approximately 52% compared to the typical daily volume of 27,996 call options.May 19, 2024 | insidertrades.comAmir Weiss Sells 15,500 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) StockMay 18, 2024 | marketbeat.comPanagora Asset Management Inc. Acquires 374,561 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Panagora Asset Management Inc. increased its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 305.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 497,202 shares of the compMay 17, 2024 | insidertrades.comVikki L. Conway Sells 15,219 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) StockMay 16, 2024 | marketbeat.comBNP Paribas Financial Markets Boosts Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)BNP Paribas Financial Markets lifted its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 22.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,425,984 shares of the compMay 16, 2024 | investorplace.comPatent Peril: 3 Stocks at Risk From the FTC's Drug CrusadeMay 16, 2024 | forbes.comChaco Vs. Teva: Which Adventure Sandal Is Right For You?May 15, 2024 | businesswire.comTeva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global OperationsMay 15, 2024 | marketbeat.comTeacher Retirement System of Texas Trims Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Teacher Retirement System of Texas lowered its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 12.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 341,487 shMay 14, 2024 | finance.yahoo.comDavid Abrams Exits Teva Pharmaceutical in Q1 2024, Reflecting Strategic Portfolio AdjustmentsMay 14, 2024 | seekingalpha.comTeva Pharmaceutical Industries Limited (TEVA) BofA Securities 2024 Health Care Conference (Transcript)May 14, 2024 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Sets New 52-Week High at $17.09Teva Pharmaceutical Industries (NYSE:TEVA) Reaches New 1-Year High at $17.09May 13, 2024 | marketbeat.comTeva Pharmaceutical Industries' (TEVA) "Overweight" Rating Reaffirmed at Piper SandlerPiper Sandler reiterated an "overweight" rating and issued a $20.00 price target (up previously from $19.00) on shares of Teva Pharmaceutical Industries in a research report on Monday.May 11, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Stake Decreased by Monaco Asset Management SAMMonaco Asset Management SAM reduced its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 10.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,367,300 shares of tMay 11, 2024 | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Rating Lowered to Buy at StockNews.comStockNews.com downgraded Teva Pharmaceutical Industries from a "strong-buy" rating to a "buy" rating in a research report on Friday.May 10, 2024 | marketbeat.comThese 7 Stocks Surged Double-Digits and Have Double-Digits to GoEarnings reports often catalyze big moves in a stock's price; the bigger the move, the more conviction the market shows. Catalysts for these moves include better-than-expected results, gained traction, and improved guidance pointing to additional upside.May 10, 2024 | marketbeat.comThese 7 Stocks Surged Double-Digits and Have Double-Digits to Go (TEVA)Stocks surging on earnings reports often continue moving higher over time. This is a look at seven that surged more than 10% on Q1 results.May 9, 2024 | msn.comTeva Pharm to launch Humira biosimilar as Q1 profit misses estimatesMay 9, 2024 | markets.businessinsider.comUBS Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)May 9, 2024 | seekingalpha.comTeva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings ResultsMay 9, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Sold by Los Angeles Capital Management LLCLos Angeles Capital Management LLC cut its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 57.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,714 shares of the company's stoMay 9, 2024 | seekingalpha.comTeva: Sustained Revenue Growth Amid Financial Strain (Rating Downgrade)May 8, 2024 | msn.comTeva, Medincell succeed in late-stage trial for injectable schizophrenia therapy Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Are you prepared for a Chinese "invasion?" (Ad)Recently declassified documents show that while the U.S has been distracted in the Middle East... China had been studying our every move... And preparing themselves for not only an armed conflict with the United States Here are 4 steps you can take RIGHT NOW >>> TEVA Media Mentions By Week TEVA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.440.91▲Average Medical News Sentiment TEVA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼86▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TAK News ALNY News GMAB News RPRX News BMRN News BGNE News VTRS News UTHR News RDY News SRPT News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored